[Histoplasmosis in AIDS patients without tegumentary manifestations]

Fernando A Messina1, Marcelo Corti2, Ricardo Negroni1

  • 1Unidad de Micología, Hospital de Enfermedades Infecciosas, Buenos Aires, Argentina.

Abstract

Insights

Early empiric treatment for AIDS-associated histoplasmosis is crucial for patients with fever, splenomegaly, and miliary lung patterns. Prompt diagnosis and treatment, especially with amphotericin B, can improve outcomes in these high-risk individuals.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Immunocompromised Host Research

Background:

  • Histoplasmosis is a significant fungal infection in Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) patients.
  • Diagnosis can be delayed for weeks, especially without skin lesions.
  • This study focuses on optimizing diagnosis and treatment for this specific patient group.

Purpose of the Study:

  • To define clinical, microbiological, and biochemical features of AIDS-associated histoplasmosis without skin lesions.
  • To establish guidelines for early empiric treatment in difficult diagnostic cases.
  • To reduce mortality associated with delayed diagnosis.

Main Methods:

  • Retrospective review of medical records for 86 histoplasmosis patients.
  • Detailed analysis of 31 patients with AIDS-associated histoplasmosis and no cutaneous lesions.
  • Evaluation of clinical symptoms, imaging, blood cultures, and serology.

Main Results:

  • Fever (96.7%) and lung involvement (70.9%) were most common; miliary pattern seen in 54.5% of lung cases.
  • Splenomegaly occurred in 19 patients.
  • High blood culture sensitivity (93.3%) contrasted with low serology positivity (23.5%).
  • Factors predicting unfavorable outcomes included CD4+ T cell count < 50 cells/μl, low albumin (< 2.5 g/dl), and pancytopenia.
  • Mortality rate was 25.8%.

Conclusions:

  • Empiric amphotericin B treatment should be considered for HIV-seropositive patients with fever, splenomegaly, and bilateral miliary lung patterns, especially if unfavorable outcome indicators are present.
  • Collecting microbiological samples before treatment initiation is vital for accurate diagnosis.
  • Early intervention is critical due to diagnostic delays and high mortality.

Related Concept Videos

Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
846
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
241
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
522
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
338
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
641
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
716